199 related articles for article (PubMed ID: 15014514)
1. Drug target identification: a question of biology.
Smith C
Nature; 2004 Mar; 428(6979):225-31. PubMed ID: 15014514
[No Abstract] [Full Text] [Related]
2. Connecting genes, drugs and diseases.
Weinstein JN; Pommier Y
Nat Biotechnol; 2006 Nov; 24(11):1365-6. PubMed ID: 17093484
[No Abstract] [Full Text] [Related]
3. Screening for drug discovery: the leading question.
Smith A
Nature; 2002 Jul; 418(6896):453-9. PubMed ID: 12140563
[No Abstract] [Full Text] [Related]
4. Drug discovery: the leading edge.
Chapman T
Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
[No Abstract] [Full Text] [Related]
5. Drug discovery in reverse.
Smith C
Nature; 2004 Mar; 428(6979):227. PubMed ID: 15014516
[No Abstract] [Full Text] [Related]
6. Scanning for success.
Jones D
Nat Rev Drug Discov; 2007 Aug; 6(8):590-1. PubMed ID: 17821827
[No Abstract] [Full Text] [Related]
7. Promises of biomarkers in drug development--a reality check.
Marrer E; Dieterle F
Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
[TBL] [Abstract][Full Text] [Related]
8. Break with tradition.
Jayaraman KS
Nature; 2006 Jul; 442(7101):342-3. PubMed ID: 16871181
[No Abstract] [Full Text] [Related]
9. Testing time for stem cells.
Baker M
Nature; 2010 Feb; 463(7282):719. PubMed ID: 20148005
[No Abstract] [Full Text] [Related]
10. The impact of systems approaches on biological problems in drug discovery.
Hood L; Perlmutter RM
Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
[No Abstract] [Full Text] [Related]
11. Drug target validation: Hitting the target.
Smith C
Nature; 2003 Mar; 422(6929):341, 343, 345 passim. PubMed ID: 12646927
[No Abstract] [Full Text] [Related]
12. Preface to the special issue "Novel pharmaconeurogenetic approaches arising from progress in translational genetics".
Renger JJ; Kern JT
J Neurogenet; 2011 Dec; 25(4):117-9. PubMed ID: 22074379
[No Abstract] [Full Text] [Related]
13. Main approaches to target discovery and validation.
Sioud M
Methods Mol Biol; 2007; 360():1-12. PubMed ID: 17172722
[TBL] [Abstract][Full Text] [Related]
14. [DNA microarrays--perspective of application for drug effectivity and safety evaluation].
Roman I
Postepy Biochem; 2008; 54(1):107-15. PubMed ID: 18610588
[TBL] [Abstract][Full Text] [Related]
15. The emergence of chemical genomics in drug discovery.
Zanders ED; Gordon RD; Gershater CJ
IDrugs; 2005 Nov; 8(11):919-23. PubMed ID: 16254786
[TBL] [Abstract][Full Text] [Related]
16. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
Fischer HP
Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
[TBL] [Abstract][Full Text] [Related]
17. Accelerating the discovery of new drug targets with chemical proteomics.
Cheung AK; Jain RK
IDrugs; 2010 Dec; 13(12):862-8. PubMed ID: 21154144
[TBL] [Abstract][Full Text] [Related]
18. The application of systems biology to drug discovery.
Cho CR; Labow M; Reinhardt M; van Oostrum J; Peitsch MC
Curr Opin Chem Biol; 2006 Aug; 10(4):294-302. PubMed ID: 16822703
[TBL] [Abstract][Full Text] [Related]
19. Brave new pharmacy.
Lemonick MD
Time; 2001 Jan; 157(2):58-66, 69. PubMed ID: 11195690
[No Abstract] [Full Text] [Related]
20. Quantitative proteomics for drug toxicity.
Gao Y; Holland RD; Yu LR
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
